Scythian Biosciences Corp. appointed Andrew DeFrancesco to its board of directors, effective Sept. 4.
DeFrancesco is chairman of Cool Holdings Inc., a Nasdaq-listed investment company.
Toronto-based Scythian Biosciences develops cannabis-derived treatments for concussions and traumatic brain injuries.